ADBiotech Co

ADBiotech Co EPS Growth

The EPS Growth of ADBiotech Co (179530.KQ) as of Nov 22, 2026 is 69.99 %. In the previous year, EPS Growth was -177.71 % — a change of -139.39% (higher).

EPS Growth

69.99 %

YoY

-139.39%

Last updated:

EPS Growth of ADBiotech Co is 2025 69.99 % . EPS Growth of ADBiotech Co was 2024 -177.71 % . It decreases by -139.39% higher compared to the previous year.

The ADBiotech Co EPS Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS Growth
Date
EPS Growth
Jan 1, 2018
-1,254.64 KRW
Jan 1, 2019
110.09 KRW
Jan 1, 2020
-1,330.71 KRW
Jan 1, 2021
64.14 KRW
Jan 1, 2022
185.17 KRW
Jan 1, 2023
-206.20 KRW
Jan 1, 2024
-177.71 KRW
Jan 1, 2025
69.99 KRW
The ADBiotech Co EPS Growth history
YEAREPS GrowthYoY
69.99 %-139.39%
-177.71 %-13.82%
-206.20 %-211.36%
185.17 %+188.68%
64.14 %-104.82%
-1,330.71 %-1,308.79%
110.09 %-108.77%
-1,254.64 %-1,008.79%
138.06 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ADBiotech Co Stock analysis

What does ADBiotech Co do? ADbiotech Co., Ltd. generates revenue by manufacturing and selling chemical products across two distinct business segments. The Veterinary Medicine segment focuses on the production of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, and synthetic antibacterial agents for use in pharmaceuticals and stockbreeding. This division serves customers in the animal health sector by providing essential medical compounds for livestock and other animals. The Supplementary Feed segment complements the core operations by manufacturing and selling functional supplementary feeds and other related products. This segment targets the stockbreeding and fisheries industries, offering nutritional solutions to enhance animal health and productivity. By combining these two segments, ADBiotech Co., Ltd. delivers a comprehensive range of chemical and feed-based solutions to its clients in Chuncheon, Gangwon-Do. ADBiotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ADBiotech Co stock

EPS Growth of ADBiotech Co is 69.99 % in 2025.

On Eulerpool you can find the complete historical development of EPS Growth ADBiotech Co since 2006 – with annual values, charts, and detailed analysis.

EPS growth measures the percentage change in earnings per share. It accounts for both profit changes and share count changes.

To evaluate EPS Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EPS Growth.

EPS Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EPS Growth's ADBiotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — ADBiotech Co

All Key Metrics — ADBiotech Co